In a highly complex healthcare environment focused on the development of customized medical products, we are seeing an increasing need for technology and information-sharing to aid decision-making, rapidly rising cost of services and treatments as well as increasingly more empowered patients. Still, one thing remains consistent – the clinicians, nurses, pharmacists and others who are absolutely committed to ensuring that every patient receives the best possible care.
PHOENIX Group, a leading healthcare provider in Europe, has been compliant with the European Union’s Falsified Medicines Directive (EU FMD) since April 20th, 2018. The company chose our Movilitas.Cloud solution to implement the FMD requirements in 17 countries for wholesale and pre-wholesale activities.
